COMPANY

Innovative Biotherapies, Inc.

HQ: Ann Arbor, MI source

Location: Ann Arbor, MI · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $797K (SBIR Phase II 5R44HL170779-03, continuation, notice Jun 9, 2026). NIH RePORTER 5R44HL170779-03 (Jun 9, 2026)
Evidence (1 event)
- Jun 9, 2026 · NIH RePORTER 5R44HL170779-03
  Organization: INNOVATIVE BIOTHERAPIES, INC.; City/State: ANN ARBOR, MI; Project number: 5R44HL170779-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-09; FY total cost (award amount): 797411; Administering IC: National Heart Lung and Blood Institute; Project title: Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals